A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler® (Symb NIS)

AstraZeneca

Status: Completed

Conditions: Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT00532922

NIS-RCN-SYM-2006/1

Details and patient eligibility

About

The purpose of this study is to investigate real practices of treatment with Symbicort Turbuhaler for 3 months in asthma and patient compliance.

Enrollment: 310 patients

Sex: All

Ages: 6+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Provision of informed consent
2. Asthmatics who has been prescribed Symbicort according to physician's judgement
3. Usage of Symbicort should follow local prescribing information

Exclusion criteria

1. Not being involved in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site)
2. No previous enrolment in the present study

Trial design

310 participants in 1 patient group

1

Description:

Chinese asthma patient prescribed Symbicort® Turbuhaler®